1. Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countries
- Author
-
Michael R. Jaff, John A. Spertus, Mariella Catalano, Rachel Forster, F. Gerald R. Fowkes, Adriana Visonà, Kun Fang, Carol Levin, Sigrid Nikol, John P. Fletcher, Lars Norgren, Ambuj Roy, N G Naidoo, William R. Hiatt, Luis Bechara-Zamudio, and Chang Shu
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Cost-Benefit Analysis ,Disease ,030204 cardiovascular system & hematology ,Amputation, Surgical ,03 medical and health sciences ,Peripheral Arterial Disease ,0302 clinical medicine ,Pharmacotherapy ,Drug Therapy ,Risk Factors ,Health care ,medicine ,Humans ,030212 general & internal medicine ,Intensive care medicine ,Exercise ,Poverty ,Randomized Controlled Trials as Topic ,business.industry ,Endovascular Procedures ,Critical limb ischemia ,Intermittent claudication ,Bypass surgery ,Amputation ,Lower Extremity ,Smoking cessation ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
Introduction Lower extremity peripheral artery disease (PAD) is increasing in prevalence in low- and middle-income countries creating a large health care burden. Clinical management may require substantial resources but little consideration has been given to which treatments are appropriate for less advantaged countries. Evidence acquisition The aim of this review was to systematically appraise published data on the costs and effectiveness of PAD treatments used commonly in high-income countries, and for an international consensus panel to review that information and propose a hierarchy of treatments relevant to low- and middle-income countries. Evidence synthesis Pharmacotherapy for intermittent claudication was found to be expensive and improve walking distance by a modest amount. Exercise and endovascular therapies were more effective and exercise the most cost-effective. For critical limb ischemia, bypass surgery and endovascular therapy, which are both resource intensive, resulted in similar rates of amputation-free survival. Substantial reductions in cardiovascular events occurred with use of low cost drugs (statins, ACE inhibitors, anti-platelets) and smoking cessation. Conclusions The panel concluded that, in low- and middle-income countries, cardiovascular prevention is a top priority, whereas a lower priority should be given to pharmacotherapy for leg symptoms and revascularisation, except in countries with established vascular units.
- Published
- 2016